Table 1.

Summary of subject characteristics.

	NC	MCI	AD
Sample size	155	276	23
SUVRROI Amyloid	1.20 ± 0.25	1.35 ± 0.32	1.59 ± 0.33
Age	76.74 ± 6.26	72.83 ± 7.96	74.61 ± 10.95
Gender (F/M)	81/74	119/157	9/14
APOE ɛ4 (carrier/noncarrier)	43/112	132/144	16/7
MMSE	28.93 ± 1.31	27.34 ± 3.25	22.78 ± 2.08
ADAS-Cog	9.49 ± 4.58	16.47 ± 9.44	30.82 ± 8.67
Sample size CSF	111	224	21
CSF-Aβ1–42 (pg/ml)	189.62 ± 52.38	172.09 ± 50.28	146.72 ± 52.03
CSF-tau (pg/ml)	72.77 ± 38.60	86.78 ± 49.61	130.93 ± 68.43
CSF-ptau (pg/ml)	34.81 ± 16.09	40.72 ± 24.92	61.71 ± 30.70